VIVET IS PARTICIPATING TO THE PAEDIATRIC CHOLESTASIS WORKSHOP - PART ONE 2020
Bernard Benichou Vivet Therapeutics' CMO will be participating to a panel and Jean-Philippe Combal, CEO and Sonia Valero, Head of Clinical Operations & Patient Advocacy Representative, will be attending the Paediatric Cholestasis Workshop – Part One on the 2nd of October 2020.
This meeting is sponsored by the British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) and European Reference Networks (ERN). The objective is to discuss how best to design clinical trials for rare paediatric cholestatic diseases in order to facilitate access to new therapy, by garnering opinion from clinicians, patients, industry and regulators on management of paediatric cholestasis, clinical trial design and access to therapy. This meeting will be followed by a 2nd workshop in May 2021 in Birmingham.
Vivet provided an educational grant to support this event.